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Introduction 
Current research in the field of endocrinology has yielded a 
considerable body of data on the cellular and intra-cellular mechan¬ 
isms of action of various hormones. In the case of some hormones, 
the precise mechanisms of action have been elucidated. A good ex¬ 
ample of such a well understood hormone action is the effect of 
epinephrine on the adenyl cyclase system found in liver (54). How¬ 
ever, in the case of the ovarian steroids, such an understanding of 
the fine points of hormone action has yet to be reached. An under¬ 
standing of the precise control exerted by the reproductive hormones 
is greatly needed to permit development of safer and more practical 
methods of human birth control. 
In an effort to gain further insight into the hormonal control 
of reproduction, the investigations to be discussed in this paper 
were undertaken. 
The following effects of ovarian steroids were examined: 
(1) the effect of progesterone and progesterone-estradiol com¬ 
binations on a soluble TPNH-DPN transhydrogenase from human pla¬ 
centa , 
(2) the effect of progesterone and estradiol on a soluble DPNH 
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oxidase from human placenta, 
(3) alterations in glycogen-phosphorylase activity in the endo¬ 
metrium of pregnant rabbits, 
(4) acute effects of intravenously administered estradiol and 
progesterone on the activity of glycogen-phosphorylase in normal 
rabbit endometrium, 
(5) Jm vitro effect of progesterone on the adenyl cyclase system 
of rabbit endometrium. 
To understand the nature of hormonal control and to serve as 
a basis for discussion of the actions of the ovarian steroids, the 
effects of hormones in general will be examined, with particular 
reference to the cellular processes susceptible to hormonal influences. 
Then a general examination will be made of the techniques by which 
the ovarian steroids might be studied, with emphasis placed on the 
usefulness and limitations of the various approaches. Finally a 
review will be made of the data gathered thus far on the biochemical 




Cellular processes susceptible to hormonal control 
SUBSTRATE SUBSTRATE 
In looking at the cellular and sub-cellular processes which 
may be readily influenced by hormones, it is useful to construct 
an idealized cell with easily identifiable compartments. The cell 
can be divided into nuclear and cytoplasmic compartments; the cy¬ 
toplasm can be further sub-divided into a soluble phase and a par¬ 
ticulate phase, the latter composed of mitochondrial and microsomal 
fractions. These divisions roughly correspond to the fractions into 
which a cell can be divided by differential centrifugation. 
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Within the nuclear compartment, cell functions which can be 
influenced by hormones are primarily those of cell division and of 
cell differentiation. In both cases the nucleus exerts a marked ef¬ 
fect on the rest of the cell, but the nuclear events are the primary 
ones being altered, and the cytoplasmic events are influenced only 
secondarily. That the ovarian steroids influence both cell division 
and differentiation is best demonstrated by changes in the endome¬ 
trium during the menstrual cycle. The early phases, before ovulation, 
during which estrogen is the dominant hormone, are marked by rapid 
cell proliferation; the later phases, during which progesterone acts 
on an estrogen-primed tissue, are marked by cellular differentiation, 
such that the endometrium becomes receptive to implantation of the 
fertilized ovum. Such effects of the steroids are difficult to exam 
ine in isolated or disrupted cells because these effects are heavily 
dependent upon observation of cytoplasmic changes in response to 
nuclear control. In fact, observation of the target tissue itself, in 
this case endometrium, is the best index of hormone action since 
the hormone response is an organized tissue response as well as 
a cellular one. 
Another aspect of hormonal control is seen in the nuclear- 
cytoplasmic relationships, in which the nucleus undergoes no appar¬ 
ent change, but the cytoplasm is influenced in such a way as to 
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alter its metabolism or to synthesize a new substance. Such nuclear 
control of cytoplasmic function is mediated through production of mes¬ 
senger-RNA (m-RNA), which in turn leads to production of a new 
protein or enzyme in the cytoplasm. According to current theories, 
hormones influence the expression of a gene or group of genes, ei¬ 
ther by causing new m-RNA to be produced or by blocking the syn. 
thesis of m-RNA already being produced (71). This m-RNA in turn 
stimulates production of specific protein or proteins within the cy¬ 
toplasm. 
It is at the level of protein synthesis under m-RNA control that 
another potential site for hormone influence exists. The protein syn¬ 
thetic apparatus must interact with the m-RNA and join the constitu¬ 
ent amino acids to one another. Hormones may interfere with the 
participation of the m-RNA or amino acids in this process. Another 
mechanism of control over the protein synthetic process would be 
through availability of energy needed to couple the amino acids to 
specific transfer-RNA (t-RNA) prior to joining into peptide linkages. 
Control over metabolic processes within the cytoplasm could 
be exerted through a great many different mechanisms. Current bio¬ 
chemical knowledge has provided well studied examples of control 
over single metabolic processes, but, unfortunately, understanding 
of the interrelationship of known examples of metabolic control is 
/>;i.j,3hoo art:; f >t bn6 i3 ?.*-£ . Oi'i, d: :w ?-.>ev. lu leuyrn aulf/:cc^f> 
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incomplete. Nonetheless, it is useful to examine some of the types 
of metabolic control which may be influenced. 
One of the basic mechanisms of metabolic control occurs through 
the activation or inhibition of a pre-existing enzyme. Similar effects 
can, of course, be produced through stimulation or inhibition of syn¬ 
thesis of the active enzyme through nuclear production of m-RNA. 
However, intra-cytoplasmic control can be exerted without addition 
or deletion of enzyme itself through direct activation or inhibition 
of the enzyme and also by hormonal influence on the presence of 
necessary co-factors, such as ions, ATP, DPN , and TPN. More 
indirect control over enzyme activity can be exerted through avail¬ 
ability of substrates, either by increased or decreased production, 
or by transport across cell and mitochondrial membranes. The hor¬ 
mone may influence the rate of a specific process through control 
of the compartmentalization of a substrate involved; for example, 
substrate sequestration within a vacuole or passage across a cell 
membrane into a mitochondrion or lysosome may be influenced. 
It is common to measure enzyme activity and to ascribe a 
change in activity to hormonal influence. However, it is most impor¬ 
tant that the conditions under which the activity change was observed 
be examined closely; the many ways by which a hormone may influence 
enzyme activity have vastly different implications in understanding 
hormone action. 
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If enzyme activity is observed in the intact animal, a change 
may represent transport from one body or organ site to another. 
In a cell capable of protein synthesis, the change may represent 
net synthesis of the active enzyme. Or, one may be observing ac¬ 
tivation of pre-existing enzyme, possibly by actual combination of 
hormone with enzyme through an allosteric effect (71). Change in 
enzyme activity may not represent activation but removal of an in¬ 
hibitor otherwise present. Since most enzyme activities are followed 
indirectly through measurement of a product of the enzyme reaction, 
an apparent change in enzyme activity leading to production of a 
given substance may actually represent an inhibition of the degrada- 
tive step which serves to remove the substance being measured. 
Furthermore, measurement of enzyme activity, usually done in homo¬ 
genates of tissues, reveals only total activity, giving no information 
on the possibility of intracellular compartmentalization of enzyme. 
substrate or co-factors. 
■■■: 2 ..'ic; /L. s-;: : ‘ . ■ • ' -- : 
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Methods of study 
Having examined the various metabolic processes over which 
hormonal control can be exerted, the methods by which these meta¬ 
bolic processes can be studied will be discussed. 
Research into the biochemical effects of ovarian steroids has 
involved the study of hormone action in the intact animal, in the 
isolated target site such as endometrium, and in fragmented tissue 
reduced to a particulate or soluble fraction by centrifugation tech¬ 
niques. 
Studies with the intact animal can be carried out using normal 
pregnant and non-pregnant animals, influenced only by naturally 
occurring endogenous hormones. Since in most cases the identities 
and relative quantities of endogenous hormones are not entirely known, 
data obtained in this manner involves certain assumptions on the part 
of the investigator with regard to the etiology of a given observation. 
The need for such assumptions can be obviated in part by super¬ 
imposing exogenous hormones upon the naturally present hormones, 
administered in physiologic or pharmacologic doses. Observed ef¬ 
fects can then be attributed to the administered hormone with some 
degree of certainty. This degree of certainty can be improved upon 
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by removing endogenous hormones through castration, hypophysectomy, 
or adrenalectomy, followed by administration of exogenous hormones. 
In any case, animals are biopsied or sacrificed at a specific 
time when they are under the regulatory influence of a specific hor¬ 
mone or group of hormones. Tissues are then analyzed for substrate 
concentration and enzyme activity. These studies make possible ex¬ 
amination of effects which can be observed only in intact animals; 
however, the investigator has difficulty in determining at what level 
of control over metabolic processes the hormone is operating. Since 
total enzyme activity or substrate concentration is being measured, 
the intermediate steps leading to the final observation are not appar¬ 
ent. Frequently it is not possible to differentiate between enzyme 
synthesis and activation, or between increased rate of substrate pro¬ 
duction and decreased rate of breakdown. The cellular events in¬ 
volved may include cell division and differentiation, enzyme synthesis 
and activation, changes in blood supply, oxygen availability, energy 
supply, and compartmental shifts. Any one of these processes may 
produce an end result of increased enzyme activity or increased 
substrate concentration. 
Studies of organs, tissues, and tissue homogenates in vitro 
allow greater control over experimental conditions so that a differen¬ 
tiation can be made among the many processes that could result in 
c.' ~ : ■ . ? ■' 
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the same observed effect. Jn vitro techniques permit the use of cer¬ 
tain specific inhibitors of protein and RNA synthesis that cannot 
be used in the intact animal due to problems of toxicity. Tissue 
culture techniques allow precise definition of incubation conditions, 
without the variables of blood flow, innervation and extraneous hor¬ 
mones. Homogenization and centrifugation permit reactions to be 
studied in the absence of possible RNA or protein synthesis. Fur¬ 
thermore, studies of a process influenced by inhibitors of RNA and 
protein synthesis provide additional information on the mechanism of 
the process being observed. 
With_in vitro methods, samples can be taken from a homogenous 
tissue and cultured under well defined conditions in the presence 
or absence of a specific hormone. Alternatively, aliquots of a com¬ 
mon homogenate, consisting of particulate or soluble fraction, can 
be compared under conditions that differ only in the addition of a 
hormone to one of the samples. These techniques permit fraction¬ 
ation and recombination of particulate and soluble fractions, produc¬ 
ing effects in combination that neither will produce alone. Thus it 
is possible to investigate hormonal effects that can be attributed 
with reasonable certainty to changes in enzyme activity, whether 
due to allosteric effects, availability of co-factors, or changes in 
substrate concentration and energy supplies. 
.saner 
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The prototype of such an investigation is the study of the 
glycogen phosphorylase-adenyl cyclase system carried out first by the 
Coris (10, 11) and later by Sutherland and Rail (43, 54). Successive 
investigations, both in vivo and _in vitro, revealed an activation 
of glycogen phosphorylase by epinephrine. The mechanism of this 
activation was shown by Sutherland and Rail to proceed through stim¬ 
ulation of adenyl cyclase by epinephrine, producing cyclic-AMP 
which in turn stimulated dephosphophosphorylase kinase, convert¬ 
ing inactive phosphorylase to its active form. This is diagrammed 
below: 
EPINEPHRINE 

















Further studies by other investigators have revealed that the adenyl 
cyclase system is an intermediary step influenced by many other 
hormones (7). Cyclic-AMP has been shown to influence numerous 
enzyme reactions in addition to the dephosphophosphorylase kinase 
conversion of inactive phosphorylase to its active form. This func¬ 
tion of cyclic-AMP as a "second messenger" will be referred to 
later in a discussion of the effects of ovarian steroids. 
Looking again at the _in vitro study of hormone effects, whereby 
a given effect may be ascribed with a high degree of certainty to 
a specific hormone, difficulty arises in determining the biological 
significance of the observed effect. The fact that steroids in a 
cell-free supernatant fraction may affect certain co-factors gives 
little information on the significance of the observed effect when 
applied to an intact animal. The _rn vitro system utilizes conditions 
to isolate and magnify a specific reaction. However, these condi¬ 
tions may bear no resemblance to cellular or tissue conditions; within 
a cell the specific enzyme reaction measured may not proceed at 
all or may proceed in a direction opposite to the one observed in 
the cell-free system. Also, the magnitude of the observed effect 
may be so small under existing intra-cellular conditions as to be 
of no significance _in vivo. The addition of ions and co-factors, the 
adjustment of pH, and the concentration of substrate in a cell-free 
.. i< .'o. a 3 )i 71 c ■ 
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system may potentiate an effect that is of no significance or may 
produce an effect that does not exist at all under normal physiologic 
conditions. 
Thus, although observation of effects _in vivo are subject to 
uncertainty as to their precise causes, their significance can usually 
be well defined. On the other hand, observations j_n vitro can be 
well defined with respect to cause but are associated with consid¬ 
erable uncertainty with respect to significance. 
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Observed biochemical effects of steroids 
It is now appropriate to review the available information on 
the biochemical effects of ovarian steroids. There exists an enor¬ 
mous body of descriptive data based on observations of reproductive 
anatomy and behavior in both animals and man. This data has been 
gathered over a period of many years, some of the most significant 
findings dating to the 1920's and 1930's, No attempt will be made 
to review or summarize this body of descriptive data. Rather, atten¬ 
tion will be focused on data, gathered mostly since 1950, that con¬ 
cerns the primary biochemical influences of ovarian steroids. 
Research in the last twenty years has shifted emphasis from 
anatomical and behavioral investigation to studies of the activity of 
various enzymes, the concentration of substrates and nucleic acids, 
and the way in which these parameters are influenced by ovarian 
steroids. Data has been collected based on studies of normal and 
treated animals, of segments of reproductive tract incubated in tissue 
culture, and of homogenates of reproductive tissue. These three 
types of systems have been examined with respect to specific alter¬ 
ations in function as a response to identifiable hormone influences. 
In reviewing the data that has been collected, an attempt will be 
, : ’. . ■; t >r. O 3 ’0 1 : i ' <; - ;br: 
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made to approach each set of experiments with a view to determining 
how the information gained aids in understanding the precise intra¬ 
cellular site of hormone action. The data will be viewed in the 
framework discussed in the preceding section on sites of hormone 
action. 
In reviewing the available data, studies will be placed into 
three main groups: (1) data obtained by measurement of enzyme acti¬ 
vity and concentration of various substances in reproductive tract 
tissue from normal animals and from those treated with hormones in 
vivo; (2) data obtained on enzyme activity in tissue slices and homo¬ 
genates incubated in vitro in the presence and absence of hormone; 
and (3) data obtained through the use of inhibitors of RNA and pro¬ 
tein synthesis. Naturally there are some experiments which fall 
into more than one of these groups, as _in vivo observations have 
been subsequently studied in in_ vitro systems. 
Some of the early data available on changes in nucleic acid 
content and in enzyme activity during the reproductive cycle is found 
in the work of Stuermer and Stein (50, 51). In one of their earlier 
papers these investigators measured RNA and DNA content of human 
endometrium as a function of the phase of the menstrual cycle, divid¬ 
ing the cycle into early and late proliferative, and early and late 
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Fig. 1 Cyclic variations in RNA and DNA content of endometrium 
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sharp increase in both RNA and DNA content during the proliferative 
phase of the menstrual cycle, with a peak immediately prior to, or 
at the time of, ovulation. In the human the endometrium is influ¬ 
enced solely by estrogens prior to ovulation. 
Also evident from the data in Figure 1 is the fact that the in¬ 
crease in RNA content is proportionately greater than the increase 
in DNA. It can thus be seen that estrogen seems to accelerate cell 
division, as shown by increasing DNA content, while at the same 
time producing a rapid RNA synthesis. Such a finding of RNA pro¬ 
duction proportionately greater than DNA production indicates that 
rapid cell growth and differentiation, associated with an increase 
in activity of the protein synthetic machinery of the cell is taking 
place. 
This protein synthetic activity is seen in the data presented in 
a later paper, in which measurements were made of succinic dehy¬ 
drogenase (SDH), malic dehydrogenase (MDH), cytochrome-C oxidase, 
and adenosine triphosphatase (ATPase) (51). As shown in Figure 2, 
the activities of all enzymes measured peaked in the early secretory 
phase, immediately after ovulation. Whether this is a function of 
rapid protein synthesis in response to estrogens, of further synthesis 
in response to progestogens, or of activation of a pre-existing enzyme 
apparatus cannot be determined. In all probability each of these 
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Fig. 2 Cyclic variations in enzyme activities during the menstrual 


































SJt 1A - ■ £ 3 








three mechanisms is active to a greater or lesser degree, and iden¬ 
tification of the primary mechanism cannot be made on the basis of 
this data alone. 
Related data is found in the work of Saldarini and Yochim, who 
studied oxygen uptake in the rat uterus as influenced by estrogen 
and progestogen (48). Their studies examined oxygen consumption 
during pseudo-pregnancy in normal rat uteri, uteri from ovariectomized 
rats, and uteri from rats treated with either progesterone or estrone 
plus progesterone. The data demonstrates a rise in oxygen consump¬ 
tion in uteri from normal rats beginning on day one of pseudo-preg¬ 
nancy and a fall in oxygen consumption after day five, during the 
phase of luteal regression. Uteri from ovariectomized animals showed 
an initial fall in oxygen consumption, followed by a rise to sub¬ 
normal levels. Treatment with progesterone gave a pattern quite 
similar to that found in normal rats, whereas treatment with estrone 
and progesterone showed elevation of oxygen consumption above nor¬ 
mal levels for the initial three days of pseudo-pregnancy, followed 
by a more rapid fall during the next three days. It was also found 
that although uteri from progesterone treated animals had near-normal 
levels of oxygen consumption during pregnancy, tissue growth did 
not occur. In uteri from animals treated with estrone in addition to 
progesterone, uterine weight followed a normal growth pattern. These 
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investigators felt their observations suggested that the high respira¬ 
tory activity of early pseudo-pregnancy reflects progestational effect 
and that growth-stimulation during the same period is due to estro¬ 
genic influences. 
An additional observation made in the same paper showed that, 
despite wide variations in uterine weight, water content varied in 
the narrow range of 80.3% to 83.9% during all phases of estrus 
and pseudo-pregnancy (48). This indicates that observed variations 
in tissue respiration and enzyme activity per gram wet weight of 
tissue were due to actual changes in metabolic activity and not due 
solely to fluctuations in water content. These findings have impli¬ 
cations in examining the data from other sources on enzyme activity 
per unit of tissue weight where determinations of variation in water 
content are not available. 
Hughes et_ al. have carried out a series of studies on the car¬ 
bohydrate pathways in human endometrium in which they measured 
the activity of numerous enzymes as well as glycogen, water and 
lactate content during the menstrual cycle (12, 28, 29 , 30). In one 
of their earlier studies, the parameters measured seemed to fall into 
two groups, those which peaked immediately before ovulation and 
those which peaked immediately after ovulation (28). The activities 
of glucose-6-phosphatase and alkaline phosphatase as well as glucose 
- o : ! r t: ■' c - ' :■ J :  r ' :T; AX ?>rJ , 5 : • : ; 
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content of human endometrium peaked 14 - 16 days after the preced¬ 
ing menstrual period. In contrast, lactic dehydrogenase, isocitric 
dehydrogenase and malic dehydrogenase activities, as well as glyco¬ 
gen and lactic acid content, peaked 17 - 19 days following the pre¬ 
ceding period. The activity of glucose-6-phosphate dehydrogenase 
was found to be unchanged. Also of interest, water content was 
found to vary from 8 0 to 83% during the proliferative phase, and 
between 78 to 84% during the secretory phase of the cycle. 
In another series of experiments Hughes ej^aj.. measured glyco¬ 
gen content, glycogen synthetase activity and glycogen phosphory- 
lase activity in endometrium from normal and infertile patients (30), 
In this study glycogen content was found to vary from 150 to 1000 mg. 
% in normals with a rapid rise during the 12th - 15th days of the cy¬ 
cle and a peak during the 16th - 20th days of the cycle. In con¬ 
trast, glycogen content in infertile patients varied between 150 and 
300 mg. %, without a rapid rise in the 12th - 15th days. Glycogen 
synthetase activity in normals showed a pattern similar to glycogen 
content, with a rapid rise in the period between the 12th and 15th 
days, and a peak between the 16th and 20th days. Again, activity 
of this enzyme in the infertile group failed to show a significant 
rise during the period from the 12th - 15th days. Both glycogen 




during the pre-ovulatory period, at which time the endometrium is 
being stimulated by estrogens alone. 
Further findings revealed that the activity of glycogen phosphor- 
ylase did not begin its rapid rise until the 16th - 20th day of the 
cycle, and did not peak until the 20th - 25th days of the cycle, 
during which time the endometrium was being stimulated by progester¬ 
one in addition to estrogen. It was concluded that estrogen initiates 
the process of glycogen synthesis, which was completed under the 
additional influence of progesterone, whereas progesterone seemed to 
have a stimulatory effect on glycogen phosphorylase necessary for 
glycogenolysis. 
Barker, Warren and others studied glucose metabolism in the 
uteri of rats treated with estradiol (5, 6, 7 0). Using glucose labelled 
14 
with C at the 1-carbon and 6-carbon positions, they found that 
carbon dioxide formation from both the C-l and C-6 positions in¬ 
creased during the first two hours after treatment. In the period 
6-24 hours after treatment, there was increased carbon dioxide 
production from the C-l carbon; the C-l/ C-6 ratio increased linearly 
after estrogen treatment. Incorporation of C-l and C-6 into lipid 
was found to be equal and to increase after estrogen treatment. 
Estradiol seemed to favor utilization of glucose via the hexose 
monophosphate shunt, and the rate of utilization was found to be 
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controlled by the amount of TPN available (6). Whether these re¬ 
sults were due to rapid synthesis of new enzymatic systems, or to 
alteration in activity of pre-existing enzymes was not determined. 
However, no change was observed in total activity of glucose-6- 
phosphate dehydrogenase or 6-phosphogluconate dehydrogenase, key 
enzymes in the hexose monophosphate pathway, 
Mueller, McCorquodale, and Herranen studied the effect of es¬ 
tradiol treatment of rats on the uterine incorporation of amino acids 
into protein (35, 38, 39). Within three hours after injection of 
estradiol, the activity of the amino acid activating enzymes in the 
105,000 x g supernatant was found to be increased. By five hours 
after injection the incorporation of labelled glycine into protein 
was found to be increased over that found in uteri from untreated 
animals. Thus an activation of the protein synthetic machinery was 
shown to occur early, followed by an increase in actual protein syn¬ 
thesis. Again, it was not possible to determine whether the in¬ 
creased activity of amino acid activating enzymes represented de 
novo synthesis or simply activation of pre-existing enzymes. 
Pincus and others studied the effect of steroids on the carbonic 
anhydrase activity in rabbit uteri, finding that enzyme activity increased 
markedly during pregnancy, beginning shortly after mating (42). This 
rise in carbonic anhydrase activity was found to be due to the effects 
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of progestins and was also found to be abolished by the administra¬ 
tion of estrogenic compounds (37, 42). Nicholls and Board studied 
the activity of carbonic anhydrase in human endometrium and found 
it to be increased by increasing the total dose and by prolonging 
the duration of therapy with oral progestins (40). Knudsen and 
others reported that the progesterone induced elevation of carbonic 
anhydrase activity in rabbit uteri could be inhibited by administra¬ 
tion of carbonic anhydrase inhibitors such as Diamox. (32). However, 
the normal proliferative response to progesterone in the rabbit was 
not affected by this treatment. The precise significance of these 
elevations of carbonic anhydrase is not clear, for no clear role in 
the metabolic processes of the endometrium has been elucidated for 
this enzyme. It is possible to speculate that the increased activity 
of carbonic anhydrase facilitates removal of carbon dioxide produced 
by both endometrium and implanting ovum, although why a require¬ 
ment exists for large increases in this enzyme awaits clarification 
in further studies. 
Szego and Davis have published some very interesting experi¬ 
ments on the effect of intravenously administered estradiol on cyclic- 
AMP levels in rat uteri (5 6, 57). They found that within fifteen 
seconds after intravenous administration of low doses of estradiol, 
total uterine content of cyclic-AMP was elevated significantly over 
• - «' 9c.:>c/ nil SiZytis lu „ i.\ 
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levels found in control animals (5 6). That this elevation of cyclic- 
AMP might be due to liberation by estrogen of a biogenic amine 
was tested by treatment of animals with a beta-adrenergic blocking 
agent prior to injection of the estradiol. Under these conditions, 
the elevation of cyclic-AMP was found to be inhibited (57). Alpha- 
adrenergic blocking agents were found to have no effect. Thus 
estrogens were shown to elevate cyclic-AMP by means of interac¬ 
tion with the beta-adrenergic receptors in the rat uterus. 
In a similar type of experiment Rosenfeld et aj., studied the 
effect of progesterone on cyclic-AMP levels and adenyl cyclase ac¬ 
tivity in the chick oviduct (47). They reported that progesterone given 
in vivo caused a delayed and progressive activation of adenyl cyclase, 
noted at three hours after treatment and becoming maximal 24 hours 
after injection. Cyclic-AMP levels were found to increase as well. 
Beta-adrenergic blocking agents did not inhibit the jm vivo adenyl 
cyclase response to progesterone, nor did epinephrine, a beta-adren¬ 
ergic stimulator, cause the enzyme to be activated. However, pro¬ 
gesterone added in vitro to homogenates of chick oviduct failed to 
produce activation of adenyl cyclase. Administration i_n vivo of a 
cyclic-AMP analog did not induce synthesis of avidin, known to be 
a specific response to progesterone (47). Thus progesterone and 
estradiol have been shown to activate adenyl cyclase in the repro- 
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ductive tract. That separate adenyl cyclase systems may be involved 
can be inferred from a difference in the time courses in the enzyme 
response to the two hormones and from a difference in susceptibility 
to blockade by beta-adrenergic blocking agents. 
In moving to the effect of added hormones on tissue slices and 
homogenates incubated m vitro, it is worthwhile to pursue further 
the demonstrated interrelationship of cyclic-AMP and estrogen. Szego 
demonstrated in another series of experiments that rat uteri incubated 
in vitro in the presence of cyclic-AMP and labelled amino acids re¬ 
vealed a stimulation of amino acid incorporation into protein (5 5). 
Hechter and others published similar observations, finding that cy¬ 
clic-AMP stimulated incorporation of amino acids into protein as 
well as synthesis of lipids, glycogen, and RNA (21, 22). This 
stimulatory effect of cyclic-AMP was found to be dependent upon 
RNA synthesis and could be abolished by addition of actinomycin 
D, an inhibitor of RNA synthesis (21). Gorski et aJL. found that the 
response of rat uteri to estradiol could be blocked by inhibition of 
RNA and protein synthesis (15). Thus cyclic-AMP and estradiol have 
been reported to have similar effects on synthesis of protein, RNA 
and lipids. 
O'Malley and others examined the effect of progesterone and 
estrogens on the chick oviduct and found that estradiol increased 
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the synthesis of RNA in the nucleus, in association with increased 
activity of nuclear RNA polymerase (41). Progesterone is known to 
stimulate the synthesis by the oviduct of a specific protein avidin; 
this stimulatory effect was thought to be due to alteration in the 
synthesis of messenger-RNA in the nucleus (41). Thus both estra¬ 
diol and progesterone were found to alter the expression of genes 
through changes in the messenger-RNA produced in the nucleus. 
In a related study, Dingman et__al. found that treatment of chicks 
with estrogen and progesterone produced a large increase in nuclear 
transfer-RNA and a small increase in cytoplasmic transfer-RNA (13). 
It was hypothesized that the transfer-RNA could be a rate limiting 
factor in protein synthesis and that hormonal control of availability 
of specific transfer-RNA species could have a regulatory effect on 
cytoplasmic protein synthesis. Stumpf has reported that in target 
tissues, radioactive labelled estradiol was found to be concentrated 
in the nuclei of the cells (52). Target tissues studied included uterus, 
vagina and oviduct; in non-target tissues such as liver and adrenal, 
no nuclear concentration of radioactive label was found. These 
findings were suggestive, as were those of O'Malley, Dingman and 
others, of a genomic effect of the hormones in target tissues of 
the reproductive tract. 
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Further data on the effect of estrogens and progesterone on 
oxidative metabolism comes from the work of Wade and Jones, who 
studied the effect of steroids on oxygen consumption and inorganic 
phosphate uptake (69). In a reaction mixture containing ATP, cyto- 
chrome-C, glucose, hexokinase, a-ketoglutarate, rat liver mitochon- 
-4 
dria and steroid, it was found that progesterone 6.4 x 10 M both 
inhibited oxygen consumption and showed a net liberation of inorganic 
phosphate. By contrast, other steroids, including estradiol, testoster¬ 
one, pregnanediol and 17 a-hydroxyprogesterone, inhibited oxygen up¬ 
take to a lesser degree, but showed a net uptake of inorganic phos¬ 
phate. Thus progesterone was the only steroid tested which produced 
a PrO ratio of zero. In the presence of other substrates progesterone 
was found to be equally effective in inhibiting oxygen consumption 
and in producing a net liberation of phosphate. Progesterone was the 
only steroid producing a net hydrolysis of ATP instead of a net syn¬ 
thesis. This data suggested that progesterone was acting to inhibit 
oxygen consumption at a site within the electron transport chain. 
Disappearance of DPNH in the mitochondrial preparation was 
found to be accelerated by progesterone as well as by the other ster¬ 
oids tested. The increase in rate of disappearance of DPNH was 
greatest in the presence of progesterone. 
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Progesterone alone was also found to inhibit the reduction of 
cytochrome C but not its oxidation. In fresh mitochondria, where ox¬ 
idation and phosphorylation remain coupled, progesterone completely 
uncoupled these two processes. As a result, progesterone was com¬ 
pared with dinitro-phenol (DNP), a known uncoupler of oxidation 
and phosphorylation. Both compounds were found to uncouple oxida¬ 
tion and phosphorylation in a similar manner. 
The fact that progesterone caused accelerated removal of hydro¬ 
gen from DPNH and at the same time inhibited cytochrome C reduction 
suggested that a site of action of progesterone occurred in the elec¬ 
tron transport chain between DPNH and cytochrome C. 
In other experiments Wade and Jones compared the effect of pro¬ 
gesterone and DNP on ATPase activity in rat liver mitochondria (68). 
Both DNP and progesterone were found to activate ATPase in the mito¬ 
chondria. Other steroids tested, including estradiol and testosterone, 
had no effect on ATPase activity. This data led to the conclusion 
that progesterone and DNP have similar modes of action on ATPase 
activity and oxidation phosphorylation in mitochondria. 
Other investigators have reported inhibition of oxygen consump¬ 
tion in response to various steroids. Guidry et_ al_. reported that es¬ 
tradiol decreased oxygen consumption of tissue homogenates (16). 
Cochran and DuBois reported that the oxidation of a-ketoglutarate by 
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whole tissue homogenates was inhibited by testosterone, ethinyl es¬ 
tradiol,, progesterone, and diethylstilbestrol; estradiol and estrone 
were found to be ineffective as inhibitors of a-ketoglutarate oxidation 
(8). This data seems to provide further evidence that steroids, and 
particularly progesterone, may effect cell processes through alteration 
of the oxidative processes with concomitant changes in concentra¬ 
tions and availability of such co-factors as DPN and ATP. 
An extended series of investigations carried out by Hagerman, 
Villee and co-workers provides further information on the effect of 
steroids on oxidative metabolism. In the early 195 0's Hagerman and 
Villee observed a cyclic variation in oxygen consumption by human 
endometrium, associated with cyclic changes in glycogen content, 
lactate production, pyruvate oxidation and carbon dioxide production 
from glucose (17). The variation in glycogen content,, suggested 
possible mediation by progesterone. Subsequently these investigators 
found that human endometrial slices, when incubated in vitro in the 
_ 0 
presence of 4 x. 10 M estradiol, showed increased oxygen consump¬ 
tion when compared to controls (18). Progesterone was found to have 
no effect. This effect of estradiol on oxygen consumption was found 
in human placenta to be due to increased activity of the Krebs cycle 
pathways, without effecting lactate production, indicating no effect 
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oxygen consumption was found to occur through increased activity of 
the citrate-isocitrate-a-ketogluterate interconversion steps. Estradiol 
was seen to have a possible effect on electron transport (60). The 
site of action of estradiol was then localized to a DPN linked isoci¬ 
trate dehydrogenase found in the 57,000 x. g supernatant of human 
placental homogenates (14 , 61, 63 , 67). Hagerman and Villee sub¬ 
sequently showed that estradiol was bound by the activated enzyme 
system, and the activity of various other hormones was examined 
(19). Active hormones included 17a-estradiol and estrone, while 
17(3-estradiol, estriol, progesterone , testosterone and stilbesterol were 
found not to effect the enzyme (64). It is of interest that a potent 
synthetic estrogen, stilbesterol, was found to be ineffective in repro¬ 
ducing the effects observed with 17(3-estradiol. 
Subsequently Talalay and Williams-Ashman reported that cataly¬ 
tic quantities of TPN greatly increased the response of placental pre¬ 
paration to estradiol (58). They found that the apparent stimulation 
by estradiol of a DPN dependent isocitrate dehydrogenase actually 
represented a coupling of a TPN-dependent isocitrate dehydrogenase 
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CO + TPNH 
2 
C02 + DPNH 
It was demonstrated that any TPNH generating enzyme, such as 
glucose-6-phosphate dehydrogenase, could be substituted for the 
isocitrate dehydrogenase. Thus the transhydrogenation reaction was 
shown to be the step sensitive to estradiol. 
Talalay and Williams-Ashman observed that in mammalian tis¬ 
sues, TPNH is present in greater concentrations than TPN, while 
DPN is present in higher concentrations than DPNH. The ratio 
jjPNlj) (pPN) is thus quite high; this ratio also represents the 
(tpn) [dpnh] 
equilibrium constant of the transhydrogenase reaction shown above. 
This was seen to have important implications regarding the activities 
of reactions dependent upon DPNH and TPNH and possible influence 
by estrogens on the DPNH and TPNH linked reactions. 
A second paper by Talalay, Hurlock and Williams-Ashman pre¬ 
sented evidence supporting the idea that the estradiol sensitive trans- 
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hydrogenase was a revisible 17 (3- hydroxy steroid dehydrogenase, with 
specificity for both TPN and DPN (59). The following reactions were 
thought to occur: 
ESTRADIOL-17(3 + DPN ESTRONE + DPNH 
ESTRONE + TPNH—>ESTRADIOL-17(3 + TPN 
SUM: TPNH + DPN DPNH + TPN 
A similar steroid dehydrogenase had been reported previously by Langer 
and Engel (33, 34). Thus it was felt that the transhydrogenation and 
dehydrogenation functions were common to a single enzyme. 
Villee and co-workers published observations which confirmed 
those of Talalay that transhydrogenation was the site of estrogen sen¬ 
sitivity (65, 66, 67). However, Hagerman and Villee then reported 
separation of the transhydrogenase activity from the dehydrogenase 
activity in placental preparations (20). This was followed by a re¬ 
port by Abe, Hagerman and Villee that an estrogen dependent trans¬ 
hydrogenase was present in human myometrium, in the absence of any 
estradiol dehydrogenase activity (1). However, this myometrial trans- 
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hydrogenase was sensitive to diethylstilbesterol, whereas the pla¬ 
cental transhydrogenase was not stimulated by this synthetic estrogen 
(2 , 58, 64). Jarabak jet ad. had reported extensive purification of the 
dehydrogenase activity from placenta and found no separation of de¬ 
hydrogenase from transhydrogenase activity (31). Thus, the question 
of whether or not the estradiol sensitive dehydrogenase and trans¬ 
hydrogenase functions of human placenta were the same or different 
enzymes could not be resolved. 
Hollander, Hollander and others studied the placental estrogen 
sensitive system and found results consistent with those of Talalay, 
supporting the idea that transhydrogenation was a function of the de¬ 
hydrogenase activity (24). These investigators also examined the 
structural specificity of the estrogen-sensitive process and found that 
a hydroxyl or keto group at position 17 was essential for activity 
(23). It was also found that 17a -dihydroequilenin had a high affin- 
tiy for the enzyme, but was devoid of any stimulating effect. 
In the above mentioned experiments on estradiol sensitive trans¬ 
hydrogenase function, enzyme activity was measured by the rate of 
appearance of DPNH produced via transhydrogenation from TPNH to 
DPN. However, none of the investigators determined the effect of 
steroids on the reaction in which DPNH was re-converted to DPN. 
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Yielding, Tomkins and others examined the effect of steroids on DPNH 
oxidation by particulate fractions from rat liver and found that steroids, 
especially progesterone, estradiol and diethylstilbesterol, inhibited 
the oxidation of DPNH (7 2). These results were thought to be inde¬ 
pendent of any transhydrogenase reaction. The mechanism of this in¬ 
hibition seemed to be by interruption of electron flow from DPNH to 
cytochrome C. Further studies indicated that the locus of steroid 
inhibition of the DPNH-cytochrome C reductase was between flavopro- 
tein and coenzyme Q or cytochrome b (73). Progesterone and estra¬ 
diol were found to act at the same site. 
Hollander and Stephens, on the other hand, reported that estro¬ 
gens activated a DPNH oxidase in particulate fractions of rat uteri 
(25). An enzyme which converted DPNH to DPN was found to be pre¬ 
sent in increased activities in the uteri of ovariectomized rats treated 
with estrogen. The relationship of these findings to those of Yield¬ 
ing and Tomkins is not at all clear. 
To summarize, ovarian steroids have been found to influence a 
great number of cell functions, including DNA, RNA, lipid and protein 
synthesis, oxygen consumption, concentration of various substances 
such as glycogen, lactate and cyclic-AMP, activities of mitochondrial 
and soluble enzymes, of carbohydrate metabolism, and hydrogen trans¬ 
fer from pyridine nucleotides. 




Results to be presented in this paper will examine further the 
effect of steroids on the placental transhydrogenase system, on a solu¬ 
ble placental DPNH oxidase, and on activation of glycogen-phosphor- 
ylase and adenyl cyclase in rabbit endometrium. 
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Materials and Methods 
Materials 
Biochemicals were obtained from Sigma Chemical Co., St. Louis, 
Missouri, and P-L Biochemicals, Inc., Milwaukee, Wisconsin. Ster¬ 
oid hormones were obtained from Mann Research Labs, New York, 
New York. Radiochemical supplier was Schwarz-Mann, Orangeburg, 
New York. Equipment and sorbents for thin-layer chromatography were 
obtained from Brinkmann, Inc., Westbury, New York. 
Methods 
I. Transhydrogenase 
Preparation of enzyme 
The method used was a modification of the one described by 
Talalay and Williams-Ashman (58). Human term placentas were ob¬ 
tained within fifteen minutes of delivery, fibrous tissue was removed 
and sections were washed in two changes of ice cold physiologic 
saline. After measurement of wet weight, the tissue was homogen¬ 
ized in 4-5 volumes of ice cold 0.25 M sucrose pH 7, using an ice 
jacketed Waring Blendor. Centrifugation was carried out at 2000 x g 
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for 15 minutes at 2° C. in a Sorvall RC2-B refrigerated centrifuge. 
The supernatant was then centrifuged at 9 0,000 x g for one hour 
at 2° C. in a Beckman model C ultracentrifuge. The supernatant was 
quick frozen in a dry ice-acetone bath and lyophilized overnight. 
The lyophilized preparation was stored at -20° C., where it was sta¬ 
ble for approximately one week. Prior to use, lyophilized enzyme 
preparation was reconstituted in 10-15 volumes of Tris buffer 0.01 M 
pH 7.4, producing an initial optical density at 340 mu of 0,4 - 
0.8 optical density units. 
Assay of transhydrogenase activity: 
Reconstituted lyophilized enzyme was centrifuged at 5,000 x g 
x 15 minutes to clear it of precipitated particles. Each cuvette con¬ 
tained 300 umoles 0.01 M Tris pH 7.4, 1.4 umoles DPN, 10 umoles 
glucose-6-phosphate, one unit glucose-6-phosphate dehydrogenase, 
5 0 umoles MgCl^, 1.0 ml. reconstituted enzyme preparation and suf¬ 
ficient distilled water to make a final volume of 3.0 ml. Hormones 
were added dissolved in 10 ul. of dioxane to give the appropriate 
_ 0 
final concentration. Estradiol 5. x 10 M, corresponded to 4 ug. 
per cuvette; progesterone at the same concentration corresponded 
to 4.62 ug. per cuvette. Control cuvettes contained 10 ul. of di¬ 
oxane without hormone. 
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Reactants plus enzyme were placed in the cuvette and optical 
density at 340 mu was recorded for 10 - 20 minutes until a stable 
baseline rate was obtained. At that point 0.02 umoles of TPN were 
added in 0.1 ml. of distilled water to initiate the transhydrogenation 
reaction. Optical densities were then followed for a further period of 
45 - 60 minutes, during which time all reactions appeared to be 
linear. 
Assay of DPNH oxidase activity 
Enzyme was prepared and reconstituted as above. Cuvettes con¬ 
tained 300 umoles 0.01 M Tris pH 7.4, 50 umoles MgCl^, 1.0 ml. 
enzyme, 0.5 umoles DPNH, and distilled water to a final volume of 
3.0 ml. Hormones were added in 10 ul. of dioxane. Reactions were 
followed for one hour at 34 0 mu, and were found to be non-linear. 
- 
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II. A. Phosphorylase activity after ovulation in rabbits: 
Post-ovulatory New Zealand white rabbits were anesthetized with 
35 mg./ kg. of pentabarbital. The reproductive tract was exposed 
and the uterine vessels on either side clamped. Uteri were excised, 
the endometrium isolated immediately and placed in ice cold 0.1 M 
NaF pH 7.0. Care was taken to isolate the tissue in ice cold NaF 
within 2-3 minutes after excision. Tissue was then blotted dry 
and its wet weight determined. Homogenization of 100 - 25 0 mg. 
of tissue per ml. of 0.1 M NaF pH 7.0 was carried out in a hand- 
powered ground glass Pyrex. homogenizer of 2 ml. capacity. Total 
volume of homogenizing fluid was 1.0 or 2.0 ml. depending on amount 
of tissue obtained. After homogenization, tissue was kept in ice where 
it was stable for up to two hours until assays were performed. All 
assays were begun within sixty minutes after homogenization. 
The phosphorylase assay was Hug's modification of Sutherland's 
assay (26, 27 , 53). Each homogenate was assayed at least in dupli¬ 
cate, both in the presence and absence of adenosine monophosphate 
(AMP). At zero time 0.1 ml. of homogenate was pipetted into 0.4 
ml. of substrate which had been incubated at 37° C. for two minutes 
previously. Substrate contained 0.032 M glucose-1-phosphate, 2% 
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glycogen, plus and minus 0.002 M AMP at pH 6.0. At 15 and 30 
minutes 0.2 ml. of reaction mixture was removed and pipetted into 
1.0 ml. of 5% TCA. Zero time samples were prepared by pipetting 
0o04 ml. of homogenate directly into 1.0 ml. of 5% TCA plus 0.16 
ml. of substrate plus and minus AMP. At the end of the reaction, 
the tubes were spun at 1,000 x g for five minutes to sediment the pro¬ 
tein precipitate, and then 0.8 ml. was removed and placed in a 15 
ml. test tube for assay of phosphate content. 
Volume was made up to 5.0 ml., 1.0 ml. of 5 N H^SO^ was 
then added and the tubes were mixed. Following this, 1.0 ml. of 
2.5% ammonium molybdate, 0o5 ml. of phosphate reducer, and dis¬ 
tilled water to a final volume of 10.0 ml. were added. Phosphate 
reducer contained 3.6 gm. Na^SO^, 36 gm. NaHSO^, and 0.6 gm. 
aminonaphtholsulfonic acid in a volume of 300 ml. The tubes were 
mixed and allowed to stand for 20 minutes, after which time they 
were read in a Klett colorimeter with a 660 mu red filter. Two phos¬ 
phate standards were prepared containing 1 uM phosphate per tube. 
Enzyme activity was calculated on the basis of the optical 
density change in 30 minutes and is expressed as umoles inorganic 
phosphate liberated / minute / gm. wet weight of tissue. 
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B. Activation of phosphorylase by intravenous steroids: 
Rabbits were anesthetized as above and after exposure of both 
uterine horns, the vessels on one side were clamped and that horn 
excised. Endometrium was immediately isolated and homogenized as 
above. After removal of one uterine horn, the animal was injected 
with a suspension of steroid in 0.9% saline with benzyl alcohol as 
a preservative. Steroid suspensions contained 10 mg./ ml.; dosages 
were 10 mg. / kg. body weight. 
Five minutes after intravenous injection of the steroid suspen¬ 
sion, the vessels of the remaining uterine horn were clamped and the 
horn removed. Tissue was then isolated and homogenized as before. 
Both the pre- and post-injection samples were then assayed for 
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III. A. Adenyl cyclase assay 
Two animals were anesthetized as before and the endometrium 
pooled and homogenized in 4 volumes Of ice cold 0.25 M sucrose, 
0.1 M PO^ pH 7.5, using a hand-driven Pyrex ground glass homogen- 
izer with 2 ml. capacity. The homogenate was split into 0.2 ml. 
aliquots to which 1 ul. of dioxane with or without hormone was added, 
to give a final concentration of steroid of 10 ^ M in the homogenate. 
The assay system was that described by Cohen and Bitensky, 
and Bitensky _et al. (4, 9). At zero time 10 ul. of homogenate with 
or without hormone was added to 10 ul. of reaction mixture which had 
been incubated at 3 0° C. The final reaction mixture contained MgSO^ 
-3 -2 -4 
3.5 x 10 M, glycylglycine 4 x. 10 M, EDTA 1 x 10 M, amino- 
-3 - 2 
phylline 6.6 x 10 M, phosphoenolpyruvate 2 x 10 M, pyruvate 
14 
kinase 2 ug., ATP-8-C (specific activity 40 - 50 mC/ mmole) 
-4 
6.6 x 10 M, and phosphate buffer 0.045 M pH 7.5. After a six 
minute incubation at 3 0° C. , tubes were placed in a boiling water 
bath for three minutes. Following this, 20 ul. of distilled water con- 
_ 2 
taining 2 x 10 M cyclic-AMP was added to each tube. Ten ul. of 
each reaction tube was spotted in duplicate on thin-layer chromatogra¬ 
phy plates prepared and run as follows. 
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B. Separation of cyclic-AMP from other nucleotides: 
Separation was done using Bitensky's modification of the tech¬ 
nique of Randerath (3, 45 , 4 6). Thin layers were prepared from a 
mixture of 18 gm. PEI cellulose, 12 gm. MN300 cellulose, 1.5 gm. 
soluble starch and 15 0 ml. distilled water which was poured on 8" 
x 20" glass plates, with a thickness of 0.5 mm. After baking dry, 
10 ul. samples of reaction mixture were spotted, 6 to 8 per plate, 
using a hot air blower to dry the samples as they were spatted. 
Plates were developed in a descending direction, using a filter paper 
wick, for nine hours with solvent A (3 0% 1 M ammonium acetate in 
water, and 70% methanol). After development with solvent A, plates 
were air dried, rewicked and run for 10 hours in solvent B (25% gla¬ 
cial acetic acid, 25% distilled water and 50% 1-butanol). Afterwards, 
plates were again air dried, the cyclic-AMP marker was located with 
short-wave ultra-violet light and the spots were shaved off. Samples 
were placed in glass vials and counted in a Packard Tri-Carb model 
3375 Scintillation counter using toluene based scintillation fluid. 
3 
Recovery of cyclic-AMP calculated from chromatography of H 
labelled cyclic-AMP was greater than 9 0%. 
. 
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Results and Discussion 
Placental transhydrogenase: 
Initially it was necessary to determine that the placental extracts 
prepared as described earlier actually possessed the capacity to trans¬ 
fer hydrogen from TPNH to DPN; also it was necessary to determine 
whether or not this hydrogen transfer activity could be stimulated by 
17(3-estradiols As seen in Figure 3, the placental extract exhibited 
a low level of transhydrogenase activity prior to the addition of TPN. 
After TPN was added, the rate of change in optical density increased 
_ 0 
markedly in the cuvette containing estradiol 5 x 10 M, but remained 
essentially constant in both the control cuvette lacking hormone and 
_ 0 
in the cuvette containing progesterone 5 x 10 M. Thus the follow¬ 
ing points were established: (1) the extract possessed transhydrogena¬ 
tion activity; (2) this activity could be stimulated by estradiol; and 
(3) progesterone, in the same concentration as that of estradiol, 
lacked any stimulatory activity when compared to the control. 
The effect of varied concentrations of hormone was then examined. 
_ 0 
Talalay and Williams-Ashman had determined that estradiol 5 x 10 M 
gave maximal stimulatory effect (58). Comparing Figures 3 and 4, 





























Fig. 3 Effect of estradiol and progesterone on placental trans- 
hydrogenase activity. 
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Fig. 4 Effect of varied concentrations of hormones on transhydro¬ 
genation. 
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increasing the concentration of estradiol to 1.25 x 10 M produces 
no additional stimulatory effect. Also, progesterone in concentra¬ 
tions of 1.25 x. 10 5 M has no stimulatory activity when compared to 
controls lacking hormone. 
The point that remained to be clarified, and one which had not 
been touched upon by any previous investigators, was the effect on 
transhydrogenase activity of estradiol and progesterone in combination. 
The possibility of an antagonistic or synergistic effect was of great 
interest since progesterone acts only upon tissue previously primed 
by estrogen. Solely in the case of an ovariectomized animal treated 
with progesterone does this hormone act on tissue which has not been 
previously influenced by estrogen. 
_ 0 
For this reason, the effect of estradiol 5 x 10 M plus proges¬ 
terone 5 x. 10 ^ M was compared to the effects of these hormones 
acting singly. In Figure 5 it can be seen that the cuvette contain¬ 
ing estradiol plus progesterone possessed approximately 10% greater 
activity than the cuvette containing estradiol alone. Again, the cu¬ 
vette containing progesterone alone demonstrated essentially no ac¬ 
tivity. In Figure 6, the effect of estradiol in combination with var¬ 
ied concentrations of progesterone was compared to the effect of estra- 
-6 -5 
diol alone. Estradiol 5 x 10 M plus progesterone 1.25 x 10 M 
















































































and 10% greater activity than estradiol 5 x. 10 Min combination with 
the same concentration of progesterone. 
It is not clear what might be the cause of this potentiation of 
the estradiol effect by progesterone. If progesterone were bound by 
the enzyme at the same site that estradiol is bound, one would expect 
that progesterone would be least partially block the effect of estra¬ 
diol when both hormones were present. If progesterone is not bound 
by the enzyme, no effect would be seen. An alternative explana¬ 
tion, which cannot be validated with the data available, is that 
progesterone may be bound by the enzyme at a site different from 
the site at which estradiol is bound. In the absence of estradiol, 
progesterone, even though bound by the enzyme, has no stimulatory 
activity. In the presence of estradiol, bound by the enzyme at a sec¬ 
ond binding site, progesterone possesses the capability of activa¬ 
ting the enzyme to levels 10 to 20% greater than those produced by 
estradiol alone. 
In the absence of separate binding sites for the two hormones, 
it is difficult to arrive at any explanation for the observed effects. 
As Hollander et_ad. reported on the structural specificity of the trans- 
hydrogenase enzyme, hormones such as dihydroequilenin could act as 
competitive inhibitors of estradiol; these hormones were bound by the 
enzyme at the same site as estradiol, thus displacing estradiol and 
i 
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inhibiting its activity (23). Such a role for progesterone would ex¬ 
plain inhibition of the estradiol effect, not the potentiation actually 
observed. Thus it seems reasonable to hypothesize the presence 
of a binding site for progesterone, separate from the estradiol site, 
that allows the progesterone to potentiate but not interfere with the 
estradiol effect. Furthermore, for progesterone to have any effect, 
estradiol must be simultaneously bound by the enzyme, as evidenced 
by the absence of any effect of progesterone alone. 
■ ■' y ■ : j:1 ' :: £ si:;: V : 
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Placental DPNH oxidase: 
The reaction being followed in studying transhydrogenase acti¬ 
vity actually involves measurement of optical density change due to 
the appearance of DPNH; the optical density change observed is the 
sum of DPNH produced by transhydrogenation from TPNH to DPN, and 
DPNH oxidized to DPN by the DPNH oxidases present in the solu¬ 
ble fraction of placenta. None of the investigators who studied the 
placental transhydrogenase actually examined the effect of steroids on 
the DPNH oxidases present in the preparation used. 
The only available data is that of Yielding and Tomkins on the 
effect of steroids on the DPNH oxidase found in the microsomal frac¬ 
tion of the liver (72). Their results showed that both progesterone 
and estradiol produced significant inhibition of DPNH oxidation. A 
comparison of the effectiveness of inhibition of DPNH oxidation by 
these two hormones revealed that progesterone was the more effective 
inhibitor. 
The findings of Yielding and Tomkins raise the possibility that 
the potentiation by progesterone of the estradiol effect on transhydro¬ 
genation might, in fact, represent inhibition of the DPNH oxidase 
by progesterone. Thus estradiol could be stimulating the production 
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of DPNH while progesterone could be inhibiting its degradation. The 
differences in activity of estradiol plus progesterone compared to es¬ 
tradiol alone might represent two different effects combining to give 
the same net result, namely the presence of a higher concentration 
of DPNH. 
The effects of estradiol and progesterone on DPNH oxidation 
were examined, using the same soluble preparation of placenta as 
was used to study transhydrogenation. The results, shown in Figure 
7, demonstrate that, contrary to the findings of Yielding and Tomkins, 
estradiol is a more effective inhibitor of DPNH oxidation than is 
progesterone. However, progesterone does possess the capacity to 
inhibit DPNH oxidation when compared to the control lacking hormone. 
Thus it is possible that the previous observation that estradiol plus 
progesterone possessed greater transhydrogenase activity than estra¬ 
diol alone may be due to the capacity of progesterone to inhibit the 
oxidation of DPNH to DPN. 
The measurement of DPNH produced is a net measurement depen¬ 
dent upon the differences in rate of reduction of DPN and the rate of 
oxidation of DPNH. Estradiol seems clearly to accelerate the rate 
of reduction of DPN, while progesterone alone has no apparent effect. 
Progesterone does have an appreciable effect on the rate of oxidation 
of DPNH. Estradiol and progesterone in combination may produce 
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Fig. 7 Effect of estradiol and progesterone on oxidation of DPNH 
by placental preparations. 
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the observed effect of increased net production of DPNH if estradiol 
stimulates the forward reaction of DPN^^DPNH, and progesterone 
inhibits the backward reaction of DPNH-^DPN. 

57 
Phosphorylase activity in the endometrium of pregnant rabbits 
In view of the results of Hughes et aH on the cyclic varia¬ 
tions of phosphorylase activity in human endometrium and the conclu- 
tions of these investigators that phosphorylase was stimulated by the 
post-ovulatory presence of progesterone (30), it was decided to study 
the activity of phosphorylase in the endometrium of the post-ovula¬ 
tory rabbit. 
The rabbit provides an ideal opportunity to study the effects of 
progesterone on endometrial enzymes because rabbit endometrium is 
in a steady-state stimulation by estrogen until the time of ovulation 
(3 6). The rabbit is one of the few animals which ovulates in response 
to mating, ovulation occurring 10 to 12 hours after mating, depending 
on the species studied (36). Immediately after ovulation, the corpus 
luteum begins producting progesterone, and progestational effects such 
as an increase in carbonic anhydrase activity can be seen (42). That 
post-ovulatory changes are mainly due to progestational hormonal in¬ 
fluence is seen by the fact that estrogens will abolish the observed 
increase in carbonic anhydrase activity after ovulation (37). 
Therefore, it was felt that post-ovulatory changes in phosphor¬ 
ylase would be due to the effects of progesterone, either as a stimu- 
■ 1. , , 




lator of synthesis of new enzyme, or as an activator of pre-existing 
enzyme. The results shown in Table I and Figure 8 reveal a rise 
in endometrial phosphorylase activity by 24 hours after mating. Fail¬ 
ure to demonstrate a rise at 12 hours after mating may indicate that 
the species of rabbit used does not ovulate until the period 12 to 
24 hours after mating. Thus, within a few hours after ovulation, 
endometrial phosphorylase activity increases significantly over con¬ 
trol values. Such a rapid rise in activity indicates either rapid in¬ 
duction and synthesis of new enzyme or activation of already present 
enzyme. 
Additional information obtained from Figure 8 shows that endo¬ 
metrial phosphorylase is activated by adenosine monophosphate (AMP). 
This indicates that the endometrial phosphorylase is of the muscle type, 
that which is activated by AMP. This finding is in agreement with 
the data of Hughes et al_. who obtained similar results with human 
endometrium (30). In contrast to endometrial phosphorylase is that 
found in rabbit liver. Experiments performed with rabbit liver revealed 
enzyme activities 30 to 5 0 times greater than those found in endome¬ 
trium. In addition, no stimulation of liver phosphorylase by AMP 
was found. 
The activity of endometrial phosphorylase is seen to peak at 
24 hours and then, to decline to levels still above those of the con- 
, '■ 
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( (jlM PC^/min. /gm. ) 











12 2. 20 2. 82 2. 51 1. 71 1. 58 1. 65 
24 5. 4 5 5. 62 5. 53 4. 34 3. 52 3. 93 
48 3. 07 3. 13 3. 09 2. 72 1. 97 2. 35 
72 3. 56 2. 98 3. 29 2. 81 2. 95 2. 88 
96 3. 16 3. 66 3. 41 2. 96 3. 34 3. 15 
120 3. 44 4. 63 3. 98 3. 18 4. 30 3. 74 
Phosphorylase activity in the endometrium of the post-ovulatory 
rabbit. See Fig. 8.. 
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trols. Enzyme activity was measured up until the fifth day after 
mating; after this period, during the sixth and seventh days, implan¬ 
tation of the fertilized ovum occurs (36). It was felt that differen¬ 
ces in endometrium due to the local effects of implantation would make 
values obtained on the sixth and seventh days after mating of ques¬ 
tionable significance. If a micro-assay system could be developed, 
requiring only 5 - 10 mg. of endometrium, it would be possible to 
examine the phosphorylase activity at the site of implantation and 
to determine if the implanting ovum has direct local effects on en¬ 
zyme activity. 
The role served by the changes in glycogen and glycogen meta¬ 
bolizing enzymes has not been precisely defined. However, it seems 
likely that the pre-ovulatory buildup of glycogen is important in pro¬ 
viding a reservoir of readily available carbohydrate to serve as an 
energy source for the implanting ovum. The post-ovulatory rise in 
phosphorylase results in liberation of large amounts of glucose into 
the endometrial cell. Presumably, either glucose or its metabolites 
are then secreted into the uterine lumen where they are available as 
an energy source. 
In humans, according to the data of Hughes _et al. , glycogen 
reaches a peak concentration of 1000 mg. % from a low of 150 mg. % 
(30). If this difference of 850 mg. % were broken down into glucose 
: I ,:’:S , 
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and secreted into the uterine lumen, a substantial glucose concentra¬ 
tion would be produced in the luminal fluid. Contrasted to this is 
the glucose concentration in human blood, which normally ranges from 
60 to 100 mg. %. Degradation of glycogen and secretion into the 
uterine lumen would produce higher concentrations of glucose within 
the lumen and facilitate entry of glucose into the ovum by diffusion. 
The ovum, prior to implantation, exists in the avascular envir¬ 
onment of the uterine lumen where it must depend upon simple diffus¬ 
ion to provide necessary metabolites and to remove waste products. 
Metabolites must enter from the uterine fluid, and waste products must 
diffuse outwards into this fluid. A high external glucose concentra¬ 
tion would accelerate diffusion into the ovum by producing a greater 
concentration gradient between the extracellular and intracellular 
fluid. 
As another consequence of an avascular environment, the ovum 
must exist in conditions of low oxygen tension since there is no 
available capillary network to provide a continuous supply of oxy¬ 
gen. Thus the ovum depends primarily on anaerobic metabolic proces¬ 
ses to provide energy prior to implantation and establishment of a 
blood supply. Comparison of the energy yield from one mole of glu¬ 
cose under aerobic and anaerobic conditions reveals that aerobic 
metabolism produces 38 moles of high-energy phosphate bonds per 
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mole of glucose, whereas anaerobic metabolism produces only 2 moles 
of high-energy phosphate bonds per mole of glucose. Under anaero¬ 
bic conditions, the cell would therefore require almost twenty times 
as much glucose to produce the necessary amounts of high-energy phos¬ 
phate bonds as it would require under aerobic conditions. A large 
amount of the energy produced by this twenty times greater quantity 
of glucose would be liberated as heat energy. 
Under anaerobic conditions the cell relies on the glycolytic 
pathways producing lactate as an end product. By producing lactate, 
the DPNH generated by an earlier step in the glycolytic pathway is 
converted back to DPN, thus eliminating the need for oxidation of 
DPNH by oxygen in the mitochondria. 
As a result of the inhibition of oxidative phosphorylation by 
progesterone demonstrated by Wade and Jones (69), the endometrium 
as well as the ovum is dependent upon anaerobic metabolism for 
energy supply. Since DPNH oxidation is inhibited by progesterone 
and estradiol as demonstrated in this paper and by Yielding and Tom¬ 
kins (7 2), DPNH must accumulate within the endometrial cells. This 
would result in acceleration of reactions requiring DPNH and inhibi¬ 
tion of reactions requiring DPN. Lack of available DPN would serve 
to inhibit Kreb's cycle metabolism, many reactions in this cycle re¬ 
quiring DPN as a hydrogen acceptor. However, for reasons mentioned 
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above, the glycolytic pathways would not be inhibited by lack of 
DPN since the pyruvate-lactate conversion serves to regenerate the 
DPN needed in an earlier step. 
Uncoupling of oxidation and phosphorylation, a property of pro¬ 
gesterone, combined with inhibition of DPNH oxidase leading to deple¬ 
tion of DPN, would result in almost complete dependence upon the 
anaerobic glycolytic pathways for energy production. Such a depen¬ 
dence upon glycolytic pathways would provide high levels of glycoly¬ 
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Effects of intravenous steroids on rabbit endometrial phosphorylase 
To examine further the effects of progesterone and estradiol on 
endometrial phosphorylase, and to provide further information on the 
mechanism by which progesterone causes a post-ovulatory rise in phos¬ 
phorylase, normal rabbits were treated with intravenous steroids. 
Hug _et al. have demonstrated in humans that intravenous glucagon 
will activate hepatic phosphorylase within 3-1/2 minutes after injec¬ 
tion when compared to levels in a pre-injection biopsy specimen of 
the patient's liver (26). With this in mind, one uterine horn was 
removed and the endometrium homogenized, intravenous injection of 
an aqueous suspension of steroid was made, and the other uterine 
horn was removed 5 minutes after injection. The activity of phosphor¬ 
ylase in the pre-injection control was compared to that in the post¬ 
injection sample. 
The data, shown in Table II, indicate that both progesterone 
and estradiol activate phosphorylase over control levels while animals 
receiving only a control injection of saline vehicle showed no differ¬ 
ence between the two samples. These results were substantiated in 
further experiments. Whether the magnitude of activation produced 




PRE-INJECTION POST-INJECTION PERCENT 
CONTROL 5 min. CHANGE 
+AMP -AMP +AMP -AMP LAMP -AMP 
PROGESTERONE 
lOmg. /kg. * 1. 20 0. 90 1. 80 1. 16 50 29 
ESTRADIOL 
lOmg. /kg. * 1. 89 1. 03 2. 34 1. 49 24 44 
CONTROL 
saline 1ml. / 2. 74 1. 78 2. 88 1. 77 5 0 
kg. 
* All hormones injected as suspensions 10 mg./ml. in 0. 9% saline 
with benzyl alcohol as preservative, 
Effect of intravenous injection of progesterone and estradiol on 
phosphorylase activity of rabbit endometrium. 
ii • . 
HO Mini - ■ 1 
<31 .1 c • OS .1 .. ■.1.... 
G .1 N£ .2 80 .1 G 3 .' 
JOKIAHTBH 
o r 
38 .2 8V .[ q ,$ 
■ i . "n1 ©t] 7 U 3 3 5 eer.omioA IIA * 
. ■ ' t -. b ■ ' - : 7.0 ' ii--: V . , '■ • q 
67 
both hormones have a definite activating effect; these effects may 
be mediated through separate activating systems. 

68 
Effect of progesterone on endometrial adenyl cyclase 
Hormones are known to activate phosphorylase through their 
action on the adenyl cyclase system (43 , 46, 54). This chain of 
activation, shown below. 
HORMONES 
I 
ADENYL CYCLASE PHOSPHODIESTERASE 







-> PHOSPHORYLASE a 
(active) 
is sensitive to hormones at the step where ATP is converted to cyclic- 
AMP. Many tissues have been shown to contain adenyl cyclase ac¬ 
tivity; however, the adenyl cyclase found in a given tissue is sen¬ 
sitive to only certain hormones (7, 54). For instance, adenyl cyclase 
from adrenal is sensitive to ACTH but not to glucagon, adenyl cyclase 
from liver is sensitive to epinephrine and glucagon, whereas skele¬ 
tal muscle adenyl cyclase is sensitive to epinephrine but not to glu¬ 
cagon (54). Thus there must exist variations in the enzyme or en- 
i ■ : -': 
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zymes which convert ATP to cyclic-AMP that cause these proteins 
to be activated by only certain of the hormones. 
In liver, which possesses adenyl cyclase activity sensitive to 
both epinephrine and glucagon, Bitensky et al. have provided evi¬ 
dence that separate adenyl cyclase systems are activated by these 
two hormones (4). Thus, in endometrium, the observed activation of 
phosphorylase by both progesterone and estradiol may be due to the 
presence of two adenyl cyclase systems, one activated by progester¬ 
one and the other by estradiol. 
Szego and Davis have shown that injections of estradiol into 
rats produce immediate increases in adenyl cyclase activity as meas¬ 
ured by a rise in total uterine cyclic-AMP levels (5 6). Rosenfeld et 
al. have shown that progesterone injections into chicks produce a 
delayed increase in levels of adenyl cyclase activity found in the 
oviduct (47). Szego and Davis further reported that beta-adrenergic 
blocking agents were capable of blocking the rise in uterine cyclic- 
AMP in response to estradiol injection (57). Rosenfeld _et al. repor¬ 
ted that the response of chick oviduct adenyl cyclase to progesterone 
was not effected by beta-adrenergic blockade (47). 
Rosenfeld et al„ were unable, however, to demonstrate bn vitro 
activation of chick oviduct adenyl cyclase by progesterone (47). Prior 
to the publication of their data, it was decided to investigate the 
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effect of progesterone _in vitro on rabbit endometrial adenyl cyclase. 
It should be noted that the results of Szego and Davis, and 
Rosenfeld et al. were obtained using, respectively, intact rat uteri, 
and whole chick oviducts. Both rat uteri and chick oviduct are com¬ 
posed of large amounts of smooth muscle tissue, which has signifi¬ 
cant adenyl cyclase activity of its own (54). Thus the effects of 
hormones on adenyl cyclase in these tissues may have been due in 
some degree to effects on the smooth muscle. Of more interest in 
terms of effects on the implanting ovum would be to determine the 
manner in which hormones influenced adenyl cyclase present in en¬ 
dometrium. 
For this reason, endometrial adenyl cyclase was assayed by the 
methods mentioned previously, in the presence and absence of proges- 
_ 0 
terone 5 x 10 M. Four samples of homogenate with and without 
hormone were incubated and each chromatographed in duplicate. No 
difference in the activity of adenyl cyclase could be demonstrated 
between the samples containing progesterone and those lacking the 
hormone. 
These results are consistent with those of Rosenfeld at aU 
but are somewhat contradictory to the observed effect of progester¬ 
one on endometrial phosphorylase. It is possible that the conditions 
of the assay used, which was the same as that used for liver, were 
. • ; 
71 
not appropriate for the endometrial enzyme system. A system that 
shows such variable sensitivity to hormones may also require variable 
reaction conditions for assay. At the present time, further work is 
being carried out to determine if suitable modification in the assay 
will reveal a stimulatory effect of progesterone on the endometrial 





Data has been presented on various in vivo and _in vitro effects 
of ovarian steroids. It has been shown that progesterone is ineffec¬ 
tive in stimulating the soluble transhydrogenase system from human 
placenta but is capable of producing 10 to 20% greater activity in 
combination with estradiol than estradiol alone produces. It was fur¬ 
ther demonstrated that estradiol and progesterone inhibit soluble DPNH 
oxidase activity in human placental preparations, with estradiol pro¬ 
ducing a greater degree of inhibition. 
The effects of steroids on rabbit endometrial phosphorylase were 
examined, with findings of an increase in phosphorylase after ovula¬ 
tion, presumably in response to progesterone. Intravenous injections 
of both progesterone and estradiol were found to produce increases 
in endometrial phosphorylase within five minutes when compared to 
pre-injection controls. These findings are indicative of possible ac¬ 
tivation of pre-existing phosphorylase through stimulation of adenyl 
cyclase. The contributions of enzyme activation and enzyme syn¬ 
thesis to the post-ovulatory rise in phosphorylase activity cannot be 
evaluated directly, but the acute effect of intravenous steroids cer¬ 
tainly seems to indicate activation of pre-existing enzyme as a sig¬ 
nificant component. 
: 
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Finally, the jin vitro effect of progesterone on rabbit endometrial 
adenyl cyclase was examined. Progesterone was found to have no 
stimulatory effect in the assay system used. In view of the acute 
effect of intravenous progesterone on phosphorylase activity, the 
possibility exists that modifications in the assay conditions may 
reveal stimulation of adenyl cyclase by progesterone. 
Ovarian steroids have been shown to effect diverse elements 
of the metabolic process, including the intracellular availability of 
the enzyme co-factors DPN, DPNH, TPN, and TPNH, and the acti¬ 
vity of enzymes leading to the production of substrates which can 




1. Abe, T. , Hagerman, D.D., and Villee, C.A, Estrogen-dependent 
pyridine nucleotide transhydrogenase of human myometrium. J. 
Biol. Chem. 239: 414 (1964). 
2. Adams, J.A., Jarabak, J. , and Talalay, P. The steroid specificity 
of the 17 [3-hydroxy steroid dehydrogenase of human placenta. 
J. Biol. Chem. 237: 3069 (1962). 
3. Bitensky, M. Personal communication. (1970) 
4. Bitensky, M0W0 , Russell, V. , and Robertson, W. Evidence for 
separate epinephrine and glucagon responsive adenyl cyclase 
systems in rat liver. Biochem. Biophys. Res. Commun. 31 : 
706 (1968). 
5. Barker, K.L., and Warren, J.C. Estrogen control of carbohydrate 
metabolism in the rat uterus: Pathways of glucose metabolism. 
Endocrinology 78.: 1205 (1965). 
6. Barker, K.L., Nielson, M.H., and Warren, J.C. Estrogen con¬ 
trol of uterine carbohydrate metabolism: Factors affecting glu¬ 
cose utilization. Endocrinology 79: 1069 (1966). 
7. Catt, K.J. Hormones in General. Lancet, April 11, 1970, p. 
763 ff. 
8. Cochran, K.W., and DuBois, K.P. The influence of certain ster¬ 
oids on the oxidation of a-keto acids. Endocrinology _55: 10 
(1954) o 
9. Cohen, K.L. , and Bitensky, M.W. Inhibitory effects of alloxan 
on mammalian adenyl cyclase. J. Pharm. and Expt, Thera. 
169: 80 (1969). 
10. Cori, C.F0, and Cori, G.T. The activity and crystallization of 
phosphorylase b. J. Biol. Chem. 158: 341 (1945). 
: 
, ". '. • . i ' ■ • . 
c. . 
' 
.. . . 
. 
. • rV.' ’ . ! . 1 •’ S.J. 
. s. 
75 
11. Cori, G.T., and Illingworth, B. The effect of epinephrine and 
other glycogenolytic agents on the phosphory.lase a content of 
muscle. Biochem. Biophys. Acta 2U 10 5 (19 56). 
12. Csermely, T. , Demers, L.M., and Hughes, E.C. Organ culture 
of human endometrium: Effects of progesterone. Obstet. Gynec. 
34: 252 (1969). 
13. Dingman, C.W. , Aronow, A., Bunting, S. L. , Peacock, A-C-, and 
O'Malley, B.W. Changes in chick oviduct RNA following hor¬ 
monal stimulation. Biochem. _8: 489 (1969). 
14. Gordon, E. E. , and Villee, C.A. Spectrophotometric studies of 
the stimulation of human placental preparations by estradiol. 
J. Biol. Chem. 216_: 215 (19 55). 
15. Gorski, J. , Noteboom, W.D., and Nicolette, J.A. Estrogen con¬ 
trol of the synthesis of RNA and protein in the uterus- J. 
Cell. Comp. Physiol. 66r sup.l 1, 91 (196 5). 
16. Guidry, M.A., Segaloff, A., and Altschu.l, A.A. Effect of a- 
Estradiol, some of its esters and estrone .on the respiration 
of tissue homogenates. Endocrinology 5J3: 29 (1952). 
17. Hagerman, D.D., and Villee, C.A. Effect of the menstrual cycle 
on the metabolism of human endometrium. Endocrinology 5_3: 
667 (1953). 
18. Hagerman, D.D., and Villee, C.A. Effects of estradiol on the 
metabolism of human endometrium in_ vitro. J. Biol. Chem. 
203 : 4 25 (19 5 3). 
19. Hagerman, D.D., and Villee, C.A. Estrogen-sensitive isocitric 
dehydrogenase. J. Biol. Chem. 229: 589 (19 57). 
20. Hagerman, D.D., and Villee, C.A. Separation of human placen¬ 
tal trans-hydrogenase from estradio.l-17(3 dehydrogenase. J. Biol. 
Chem 234: 20 31 (19 59). 
« • • • t ir: .! 
■r {il . ■ 
. . . . 
' 
. : 
... . • . ...• r Ji: . 
. 
. . .... 
... 
, f . . . ■ 
. 






t • • 
. . 
76 
21. Hechter, O.K., Yoshinaga, K. , Cohn, C., Dodd, P. , and Hal- 
kerston, I.D.K. In vitro stimulatory effects of nucleotides and 
nucleosides on biosynthetic processes in castrated rat uterus. 
Federation Proc. _24: 384 (19 65). 
22. Hechter, O.K., Yosinaga, K. , Halkerston, I.D.K. , and Birchall, 
K. Estrogen-like anabolic effects of cyclic 3’, 5' adenosine 
monophosphate and other nucleotides in isolated rat uterus. 
Arch. Biochem. Biophys. 122: 449 (1967). 
23. Hollander, V.P. , Nolan, H., and Hollander, N. The structural 
specificity of the estrogen sensitive enzyme system in placental 
homogenates. J. Biol. Chem. 233: 580 (1958). 
24. Hollander, V.P., Hollander, N., and Brown, J0D. Studies on 
the estrogen-sensitive enzyme system from placenta. J. Biol. 
Chem. 234: 1678 (1959). 
25. Hollander, V.P., and Stephens, M0L. Studies on phenol-acti¬ 
vated oxidation of reduced nucleotides of rat uterus. J. Biol. 
Chem. 234: 1901 (1959). 
26. Hug, G., Schubert, W.K., and Schwachman, H. Imbalance of 
liver phosphorylase and accumulation of glycogen in a girl 
with progressive disease of the brain. J. Ped. _67: 741 (1965). 
27. Hug, G., Schubert, W.K., and Chuck, G. Deficient activity of 
dephosphophosphorylase kinase and accumulation of glycogen in 
the liver. J. Clin. Invest. _48: 7 04 (19 69). 
28. Hughes, E.C., Jacobs, R.D., Rubulis, A., and Husney, R.M. 
Carbohydrate pathways of the endometrium: Effects on ovular 
growth. Am. J. Obstet. Gynec. 8_5: 594 (1963). 
29. Hughes, E.C., Jacobs, R.D., and Rubulis, A. Effect of treat¬ 
ment for sterility and abortion upon the carbohydrate pathways 
of the endometrium. Am. J. Obstet. Gynec. 89: 59 (1964). 
30. Hughes, E.C0, Demers, L.M., Csermely, T., and Jones, D.B. 
Organ culture of human endometrium: Effect of ovarian steroids. 
Am. J. Obstet. Gynec. 105: 707 (1969). 

77 
31. Jarabak, J. , Adams, J.A., Williams-Ashman, H.G., and Talalay, 
P. Purification of a 17-- {3 hydroxy steroid dehydrogenase of human 
placenta and studies on its transhydrogenase function. J. Biol. 
Chem. _237: 345 (1962). 
32. Knudsen, K.A. , Jones, R.C., and Edgren, R.A. Effect of a car¬ 
bonic anhydrase inhibitor (Diamox) on the progesterone stimu¬ 
lated rabbit uterus. Endocrinology 85_: 1204 (19 69). 
33. Langer, L.J. , and Engel, L.L. Human placental estradiol-17(3 
dehydrogenase. Federation Proc. 15: 29 6 (19 5 6). 
34. Langer, L.J., and Engel, L.L. Human placental estradiol-17(3 
dehydrogenase. J. Biol. Chem. 233: 583 (1958). 
35. McCorquodale, D.J., and Mueller, G.C. Effect of estradiol on 
the level of amino acid-activating enzymes in the rat uterus. 
J. Biol. Chem. 232: 31 (1958). 
36. Marshall's Physiology of Reproduction. Editor A.S. Parkes. 
Longmans, Green and Co., Ltd., London (1956), p. 257 ff. 
37. Miyake, T. , and Pincus, G. Anti-progestational activity of 
estrogens in rabbit endometrium. Proc. Soc. Expt. Biol. Med. 
99_: 478 (1958). 
38. Mueller, G.C. , and Herranen, A. Metabolism of one-carbon 
fragments by surviving uteri from estradiol-treated rats. J. 
Biol. Chem. 219: 585 (195 6). 
39. Mueller, G.C. Some biochemical studies on the mechanism of 
activity of estrogens. Cancer H): 716 (1957). 
40. Nicholls, R.A. , and Board, J.A. Carbonic anhydrase concentra¬ 
tion in endometrium after oral progestins. Am. J. Obstet. 
Gynec. 9_9: 829 (1967). 
41. O'Malley, B.W., McGuire, W.L., Kohler, P.O., and Korenman, 
S.G. Studies on the mechanism of steroid hormone regulation 
of synthesis of specific proteins. Recent Progr. Hormone Res. 
_25: 105 (1969). 
42. Pincus, G., and Bialy, G. Carbonic anhydrase in steroid-re¬ 
sponsive tissues. Recent Progr. Hormone Res. 21: 201 (1963). 
,«: . , . ■ ‘jj x ; .. i 
* ef ■ • 
- 
, , v J , « , l" 
■ • 
. , x , , , 
, 
x * HJ' , , ' ; , . 
' j : . „ x: 
, 
:  
‘ ' ' :.. ■ j . - v; ; ; : •' 9 > 
78 
43. Rail, R0W., Sutherland, E.W. , and Berthet, J. The relationship 
of epinephrine and glucagon to liver phosphorylase. J. Biol. 
Chem0 124: 463 (1957). 
44. Randerath, K., and Randerath, E. Ion-exchange chromatography 
of nucleotides on poly (ethyleneimine)-cellulose thin layers. 
J. Chromatog. 1&: 111 (19 64). 
45. Randerath, K. Separation of constituent nucleotides of nucleic 
acids on ion-exchange thin layers. Pro Experimentis _20: 4 06 
(1965). 
46. Robison, G.A., Butcher, R.W. , and Sutherland, E.W. On the 
relation of hormone receptors to adenyl cyclase; in Fundamen¬ 
tal Concepts in Drug-Receptor Interactions. Academic Press, 
New York (197 0), p. 59 ff. 
47. Rosenfeld, M.G., Kissel, J.H., and O'Malley, B.W. Proges¬ 
terone effects on adenyl cyclase activity and cyclic adenosine 
3', 5'-monophosphate levels in the chick oviduct. Cytobios 
5: 33 (1970). 
48. Saldarini, R„J. , and Yochim, J.M. Metabolism of the uterus 
of the rat during early pseudo-pregnancy and its regulation by 
estrogen and progesterone. Endocrinology 8_0: 453 (1967). 
49. Spiegel, A.M., and Bitensky, M.W. Effects of chemical and 
enzymatic modifications of glucagon on its activation of hepa¬ 
tic adenyl cyclase. Endocrinology 8_5: 638 (19 69). 
50. Stein, R.J. , and Stuermer, V.M. Cytodynamic properties of 
human endometrium, III. Variations in the nucleoprotein content 
of the endometrium during the menstrual cycle. Am. J. 
Obstet. Gynec. j61: 414 (1951). 
51. Stuermer, V.M., and Stein, R.J. Cytodynamic properties of the 
human endometrium, V. Metabolism and the enzymatic activity 
of the human endometrium during the menstrual cycle. Am. J. 
Obstet. Gynec. _6_3: 359 (1952). 
3 
52. Stumpf, W.E. Nucleic concentration of H-estradiol in target 
tissues. Dry mount autoradiography of vagina, oviduct, ovary, 
testes, mammary tumor, liver and adrenal. Endocrinology 85: 
31 (1969). 
. 
v :" ' , , 
■ 
. . ' ‘ ‘ , „ ; : , , .. 
\ <* t ■ 
■ 
: .v . '.. 
, , , . ■ .■ , ■ rA 
• . 
■» . » i : . J- I : r ' ' : : . 
■. ' ' ’ 1 ■ ■■ v'-2 • ; 
. 
> ' •' r I?:; , -j'P : 
79 
53. Sutherland, E.W. Polysaccharide phosphorylase, liver; in Methods 
in Enzymology. S.P. Colowick and N. Kaplan, editors. Aca¬ 
demic Press, Inc., New Fork (1955), p. 215 ff. 
54. Sutherland, E.W. , and Rail, T.W. The relation of adenosine¬ 
s', 5'-phosphate and phosphorylase to the actions of catecho¬ 
lamines and other hormones. Pharmacol. Rev. 12: 265 (1960). 
55. Szego, C.M. Role of histamine in the mediation of hormone 
action. Fed. Proc. _24: 1343 (1965). 
56. Szego, C.M., and Davis, J. S. Adenosine 3', 5'-monophosphate 
in rat uterus: acute elevation by estrogen. Proc. Natl. Acad. 
Sci. U.S. _58: 1711 (1967). 
57. Szego, C. M. , and Davis, J. S. Inhibition of estrogen-induced 
elevation of cyclic 3', 5'-adenosine monophosphate in rat uter¬ 
us: I. By (3-adrenergic receptor blocking drugs. Mol. Phar¬ 
macol. _5: 470 (1969). 
58. Talalay, P., and Williams-Ashman, H.G. Activation of hydrogen 
transfer by steroids. Proc. Natl. Acad. Sci. U.S. 4_4: 15 (1958). 
59. Talalay, P. , Hurlock, B. , and Williams-Ashman, H.G. On a 
co-enzymatic function of estradiol 17-(3. Proc. Natl. Acad. 
Sci. U.S. 44: 862 (1958). 
60. Villee, C.A., and Hagerman, D. D. Effect of estradiol on the 
metabolism of human placenta vitro. J. Biol. Chem. 205: 
873 (1953). 
61. Villee, C.A. An estradiol-induced stimulation of citrate utiliza¬ 
tion by placenta. J. Biol. Chem. 215: 171 (1955). 
62. Villee, C.A., and Gordon, C.C. Further studies on the action 
of estradiol jin_ vitro. J. Biol. Chem. 216: 203 (1955). 
63. Villee, C.A. Role of estrogens in regulating the metabolism of 
the placenta and endometrium. Fertility and Sterility _8: 156 
(1957). 
64. Villee, C.A., and Hagerman, D.D. Compounds with antiestrogenic 
activity in vitro. Endocrinology J50: 552 (1957). 
, •• 
. C*> .C . 







• * * 
80 
65. Villee, C.A. , and Hagerman, D.D. On the identity of the estro¬ 
gen sensitive enzyme of human placenta. J. Biol. Chem. 233: 
42 (1958). 
66. Villee, C.A. , Loring, J.M., and Sarner, A.M. The isocitric 
dehydrogenases of the placenta. Federation Proc. JJ7: 328 (1958). 
67. Villee, C.A. Estrogens and uterine enzymes. Ann. NY Acad. 
Sci. A5: (2) 524 (1959). 
68. Wade, R. , and Jones, H.W. Effect of progesterone on mitochon¬ 
drial ATPase. J. Biol. Chem. 220: 547'(1956). 
69. Wade, R. , and Jones, H.W. Effect of progesterone on oxidative 
phosphorylation. J. Biol. Chem. 220: 553 (1956). 
70. Warren, J. C., Cheatum, S.G., Greenwald, G. S. , and Barker, 
K. L. Cyclic variation of uterine metabolic activity in the 
golden hamster. Endocrinology _80: 714 (1967). 
71. Watson, J. D. Molecular Biology of the Gene. W. A. Benjamin, 
Inc., New York, 19 65. 
72. Yielding, K. L. , and Tomkins, G. M. Inhibition of the enzymic 
oxidation of DPNH by steroid hormones. Proc. Natl. Acad. 
Sci. U.S. _45: 1730 (1959). 
73. Yielding, K. L. , Tomkins, G.M., Munday, J. S. , and Cowley, I. J. 
The effect of steroids on electron transport. J. Biol. Chem. 




• ... . 
t.1' 
. 
. . ' . 







YALE MEDICAL LIBRARY 
Manuscript Theses 
Unpublished theses submitted for the Master's and Doctor's degrees and 
deposited in the Yale Medical Library are to be used only with due regard to the 
rights of the authors. Bibliographical references may be noted, but passages 
must not be copied without permission of the authors, and without proper credit 
being given in subsequent written or published work. 
This thesis by has been 
used by the following persons, whose signatures attest their acceptance of the 
above restrictions. 
NAME AND ADDRESS DATE 

